Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A **DNA cross-linking agent target site on a DNA strand refers to specific locations within the double-stranded structure where exogenous chemicals—such as alkylating agents or platinum-based drugs—form covalent bonds between nucleotide bases either within one strand (intrastrand) or across both strands (interstrand). These lesions block essential cellular processes like replication and transcription by physically preventing separation or proper alignment of the two strands. While not themselves proteins or classical drug targets, these sites are critical mediators in chemotherapy-induced cytotoxicity against rapidly dividing cancer cells. The inability to repair such lesions leads ultimately to cell death through mitotic catastrophe or apoptosis.[1][2][3]
Drugs that interact with this site act by: - Forming covalent bonds between two nucleotides within one strand (intrastrand) or across both strands (interstrand) of the double helix. - Blocking separation and proper function of the strands during replication/transcription. - Triggering cell cycle arrest and apoptosis due to irreparable damage.[1][3]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA cross-linking site on DNA strand (None established; commonly referred to as "DNA cross-link" or "DNA crosslink site").